FDA removes hold on three CARsgen CAR-T trials; Ono passes on itolizumab

Plus, news about Kymera Therapeutics, Nanoscope, Eupraxia, Alpha Cognition and EyePoint:

FDA’s decision on CARsgen’s CAR-T therapies: The FDA on Thursday

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Phone use at night worsens sleep and mental health in kids, especially cyberbullying victims

The impact of nighttime phone use on sleep and mental health is significant, with cyberbullying intensifying psychological distress in children and adolescents.

September 6, 2024

Masimo shareholders elect activist investor’s two board candidates

Dive Brief: The shareholders of pulse oximeter maker Masimo elected both candidates nominated by activist investor Politan Capital Management to the company’s board of directors

June 27, 2023

The contribution of transcription factor ROB1 to the pathophysiology of C. albicans-induced candidal infections

Researchers evaluated the function of the zinc finger transcription factor ROB1 and its two phenotypically distinct alleles in the pathogenesis of Candida albicans infections.

June 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.